000 01372 a2200409 4500
005 20250516093551.0
264 0 _c20121004
008 201210s 0 0 eng d
022 _a1365-2796
024 7 _a10.1111/j.1365-2796.2012.02558.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKupczyk, M
245 0 0 _aU.S. and European severe asthma cohorts: what can they teach us about severe asthma?
_h[electronic resource]
260 _bJournal of internal medicine
_cAug 2012
300 _a121-32 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdult
650 0 4 _aAnti-Asthmatic Agents
_xtherapeutic use
650 0 4 _aAsthma
_xepidemiology
650 0 4 _aChild
650 0 4 _aCross-Sectional Studies
650 0 4 _aDrug Resistance
650 0 4 _aEurope
_xepidemiology
650 0 4 _aGlobal Health
650 0 4 _aHumans
650 0 4 _aInternational Cooperation
650 0 4 _aLongitudinal Studies
650 0 4 _aPhenotype
650 0 4 _aRespiratory Therapy
_xmethods
650 0 4 _aRisk Assessment
650 0 4 _aRisk Factors
650 0 4 _aSeverity of Illness Index
650 0 4 _aUnited States
_xepidemiology
700 1 _aWenzel, S
773 0 _tJournal of internal medicine
_gvol. 272
_gno. 2
_gp. 121-32
856 4 0 _uhttps://doi.org/10.1111/j.1365-2796.2012.02558.x
_zAvailable from publisher's website
999 _c21811410
_d21811410